These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33831417)

  • 1. PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding.
    Soares AC; Ferreira A; Mariën J; Delay C; Lee E; Trojanowski JQ; Moechars D; Annaert W; De Muynck L
    J Biol Chem; 2021; 296():100636. PubMed ID: 33831417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteopathic tau seeding predicts tauopathy in vivo.
    Holmes BB; Furman JL; Mahan TE; Yamasaki TR; Mirbaha H; Eades WC; Belaygorod L; Cairns NJ; Holtzman DM; Diamond MI
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4376-85. PubMed ID: 25261551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
    Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the endolysosomal pathway and exosome release in tau propagation.
    Yan M; Zheng T
    Neurochem Int; 2021 May; 145():104988. PubMed ID: 33582164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
    Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
    J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of mouse models to study cell-to-cell transmission of pathological tau.
    Narasimhan S; Lee VMY
    Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol.
    Polanco JC; Hand GR; Briner A; Li C; Götz J
    Acta Neuropathol; 2021 Feb; 141(2):235-256. PubMed ID: 33417012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry.
    Furman JL; Holmes BB; Diamond MI
    J Vis Exp; 2015 Dec; (106):e53205. PubMed ID: 26710240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology.
    Wiersma VI; van Ziel AM; Vazquez-Sanchez S; Nölle A; Berenjeno-Correa E; Bonaterra-Pastra A; Clavaguera F; Tolnay M; Musters RJP; van Weering JRT; Verhage M; Hoozemans JJM; Scheper W
    Acta Neuropathol; 2019 Dec; 138(6):943-970. PubMed ID: 31456031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum.
    Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
    DeVos SL; Miller RL; Schoch KM; Holmes BB; Kebodeaux CS; Wegener AJ; Chen G; Shen T; Tran H; Nichols B; Zanardi TA; Kordasiewicz HB; Swayze EE; Bennett CF; Diamond MI; Miller TM
    Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
    Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
    J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockin' on heaven's door: Molecular mechanisms of neuronal tau uptake.
    De La-Rocque S; Moretto E; Butnaru I; Schiavo G
    J Neurochem; 2021 Mar; 156(5):563-588. PubMed ID: 32770783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation.
    Li L; Miao J; Chu D; Jin N; Tung YC; Dai CL; Hu W; Gong CX; Iqbal K; Liu F
    CNS Neurosci Ther; 2022 Dec; 28(12):2245-2259. PubMed ID: 36114722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.
    Nieznanska H; Boyko S; Dec R; Redowicz MJ; Dzwolak W; Nieznanski K
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166209. PubMed ID: 34246750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.